Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pivya vs Nitrofurantoin in Female Pediatric Subjects with Uncomplicated Urinary Tract Infections
NCT07871968Phase 2Not yet recruiting
- Sponsor
- Alembic Therapeutics, Inc.
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of dapagliflozin in urinary tract infection (UTI), sponsored by Alembic Therapeutics, Inc.. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
dapagliflozin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT07871968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07871968.